Microba Life (Australia) Today
| MAP Stock | 0.26 0.02 7.14% |
Performance13 of 100
| Odds Of DistressLess than 22
|
Microba Life is selling for under 0.26 as of the 1st of February 2025; that is 7.14 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.25. Microba Life has about a 22 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat good performance during the last 90 days. The performance scores are derived for the period starting the 2nd of January 2025 and ending today, the 1st of February 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | Category Healthcare | Classification Health Care |
Microba Life is entity of Australia. It is traded as Stock on AU exchange. The company has 447.85 M outstanding shares. More on Microba Life Sciences
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Microba Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Microba Life's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Microba Life or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, Health Care, Health Care Providers & Services, Health Care Equipment & Services, Health Care (View all Sectors) | ||||
Microba Life's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Microba Life's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsMicroba Life can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Microba Life's financial leverage. It provides some insight into what part of Microba Life's total assets is financed by creditors.
| |||||
Microba Life Sciences (MAP) is traded on Australian Securities Exchange in Australia and employs 12 people. Microba Life is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 116.44 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Microba Life's market, we take the total number of its shares issued and multiply it by Microba Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Microba Life Sciences operates under Health Care Providers & Services sector and is part of Health Care industry. The entity has 447.85 M outstanding shares.
Microba Life Sciences has accumulated about 12.43 M in cash with (15.57 M) of positive cash flow from operations.
Check Microba Life Probability Of Bankruptcy
Ownership AllocationMicroba Life Sciences maintains a total of 447.85 Million outstanding shares. Microba Life Sciences holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Microba Ownership Details
Microba Life Sciences Risk Profiles
Although Microba Life's alpha and beta are two of the key measurements used to evaluate Microba Life's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.65 | |||
| Semi Deviation | 3.47 | |||
| Standard Deviation | 4.91 | |||
| Variance | 24.14 |
Microba Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Microba Life without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
Microba Life Corporate Management
Elected by the shareholders, the Microba Life's board of directors comprises two types of representatives: Microba Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Microba. The board's role is to monitor Microba Life's management team and ensure that shareholders' interests are well served. Microba Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Microba Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Wood | Head Operations | Profile | |
| Luke Reid | Chief Officer | Profile | |
| Yao Liu | Chief Officer | Profile | |
| Nicola Angel | Head Operations | Profile | |
| Pr Krause | Chief Officer | Profile | |
| Pr Munro | Senior Therapeutics | Profile |
Additional Tools for Microba Stock Analysis
When running Microba Life's price analysis, check to measure Microba Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microba Life is operating at the current time. Most of Microba Life's value examination focuses on studying past and present price action to predict the probability of Microba Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microba Life's price. Additionally, you may evaluate how the addition of Microba Life to your portfolios can decrease your overall portfolio volatility.